Skip to content

Detailed Organ System Analysis of Asymptomatic COVID19 patients using noninvasive mobile tool

Non Invasive Detection and Monitoring of Corona Virus from Lyfas Mobile tool

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/05/025345
Enrollment
100
Registered
2020-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Acculi Labs PvtLimited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects must be divided into two major groups: A) Controlled Group B) Uncontrolled Group Control Group: Proven cases of COVID-19 with or without other health issues like COPD, DM, HTN etc Uncontrolled Group: Asymptomatic patients who are not COVID-19 positive, which can be either those who tested negative or normal public.

Exclusion criteria

Exclusion criteria: 1. Terminally ill patients with severe pneumonia 2. Patients with sepsis 3. Patients on ventilator 4. Patients below age of 5 years 5. Patients not willing to give written informed consent

Design outcomes

Primary

MeasureTime frame
The study should prove that Lyfas corona Virus Profile indicator can be used to detect corona virus risk at an asymptomatic stage and can be used to monitor the suspected person with significant statistical correlation in range of patients with different clinical and demogroaphic background.Timepoint: Day 1,3,6 and 10.

Secondary

MeasureTime frame
To know the turn around time of the test.Timepoint: Same day

Countries

India

Contacts

Public ContactRishikesh Ranjan

Medanta Institute of Education and Research

pooja.sharma@medanta.org0124-4141414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026